Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 05 Oct 2026 for CORCEPT THERAPEUTICS INC, €9,689. Read the official filing
Filing timeline
BuySaleJoseph Douglas Lyon
Insider track record
Disclosed buys
0
Disclosed sells
9
Signal history
Joseph Douglas Lyon: trading record in brief
Joseph Douglas Lyon discloses dealings in Corcept Therapeutics Inc to SEC (Form 4). The record holds 54 filings, for trades running from 1 March 2023 to 2 October 2026.
On the market, this insider has only sold: 9 sales, €2.5M in total. Outside the open market, there are 13 share grants and 32 option exercises. In 2026 alone, the filings show no purchases and 7 sales.
The record was last updated on 5 October 2026 with an option exercise (€9,689) in Corcept Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joseph Douglas Lyon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations54 total
810 shares@ US$13.56Common StockSEC:0001193125-26-414684:0
810 shares@ US$115.3985Common StockSEC:0001193125-26-414684:1
3,357 shares@ US$13.56Common StockSEC:0001193125-26-414684:2
5,833 shares@ US$19.26Common StockSEC:0001193125-26-414684:3
4,446 shares@ US$115.697Common StockSEC:0001193125-26-414684:4
4,744 shares@ US$116.5407Common StockSEC:0001193125-26-414684:5
2,596 shares@ US$11.350.0002% mcap0.6% of flowCommon StockSEC:0001193125-26-393125:0
7,404 shares@ US$13.560.0008% mcap2.0% of flowCommon StockSEC:0001193125-26-393125:1
7,812 shares@ US$113.32060.0069% mcap17.2% of flowCommon StockSEC:0001193125-26-393125:2
2,188 shares@ US$114.11630.0020% mcap4.9% of flowCommon StockSEC:0001193125-26-393125:3
130 shares0Common StockSEC:0001193125-26-382450:1
130 shares@ US$113.380.0001% mcap0.3% of flowCommon StockSEC:0001193125-26-382450:0
72 shares@ US$113.380.0001% mcap0.2% of flowCommon StockSEC:0001193125-26-382450:2
1,540 shares@ US$114.160.0014% mcap100.0% of flowCommon StockSEC:0001193125-26-335605:0
537 shares@ US$70.440.0003% mcap0.7% of flowCommon StockSEC:0001193125-26-256022:0
269 shares@ US$70.440.0002% mcap0.4% of flowCommon StockSEC:0001193125-26-256022:2
537 shares0Common StockSEC:0001193125-26-256022:1
5,000 shares@ US$65.000.0026% mcap6.3% of flowCommon StockSEC:0001193125-26-248977:0
398 shares@ US$35.970.3% of flowCommon StockSEC:0001193125-26-092166:0
5,000 shares@ US$13.561.3% of flowCommon StockSEC:0001193125-25-307229:0
5,000 shares@ US$13.561.3% of flowCommon StockSEC:0001193125-25-267548:0
5,000 shares@ US$13.561.3% of flowCommon StockSEC:0001193125-25-230440:0
5,000 shares@ US$13.561.3% of flowCommon StockSEC:0001193125-25-196317:0
5,823 shares@ US$13.561.6% of flowCommon StockSEC:0000950170-25-103319:0
3,877 shares@ US$13.561.0% of flowCommon StockSEC:0000950170-25-097371:0
25 of 54 declarations
